Gynecologic radiation therapy in low and middle income countries during the COVID-19 pandemic

Int J Gynecol Cancer. 2022 Mar;32(3):446-450. doi: 10.1136/ijgc-2021-003039.

Abstract

The COVID-19 pandemic has forever affected healthcare and posed an incredible challenge to our society to care for our sick. Patients with cancer were found early on to have higher rates of complications with COVID-19. Radiation therapy is an integral part of treatment for many types of gynecologic cancer and adaptation on its utilization during the pandemic varied across the globe. In this review, we detail certain guidelines for the use of radiation in gynecologic cancers during the pandemic as well as real world accounts of how different countries adapted to these guidelines or created their own based on individualized resources, staffing, government restrictions, and societal norms. Critically, this review demonstrates the breadth of fractionation schemes and technologies used when resources were limited but highlights the importance of long term follow-up for many of our patients during this time.

Keywords: COVID-19; brachytherapy; radiation oncology.

Publication types

  • Review

MeSH terms

  • Adult
  • COVID-19 / prevention & control
  • COVID-19 / transmission
  • Developing Countries / statistics & numerical data*
  • Female
  • Genital Diseases, Female / epidemiology
  • Genital Diseases, Female / therapy*
  • Humans
  • India / epidemiology
  • Internet
  • Middle Aged
  • Radiotherapy / standards
  • Radiotherapy / statistics & numerical data*
  • Surveys and Questionnaires